date,title,source
Nov-14-18,Pulmatrix Reports Q3 2018 Results,PR Newswire
Nov-15-18,"Pulmatrix to Present Results from the Pulmazole (PUR1900) Phase 1/1b Study at the 2018 Annual Scientific Meeting of the American College of Allergy, Asthma, and Immunology",PR Newswire
Nov-21-18,Pulmatrix Announces Positive Final Results from the Phase 1/1b Clinical Trial of Pulmazole - an Inhaled Dry-Powder iSPERSE Formulation of Itraconazole,PR Newswire
Nov-29-18,Pulmatrix Announces $3.0 Million Registered Direct Offering,PR Newswire
Jan-28-19,"Pulmatrix, Inc. Announces Proposed Public Offering of Common Stock",PR Newswire
Jan-30-19,"Pulmatrix, Inc. Announces Pricing of Public Offering of Common Stock",PR Newswire
Jan-30-19,"Pulmatrix, Inc. Announces Proposed Public Offering of Common Stock",PR Newswire
